Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Duke Energy Corp (DUK) vs 10X Genomics Inc (TXG) Price & Performance

Duke Energy CorpTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Duke Energy Corp vs 10X Genomics Inc — how do they compare? Duke Energy Corp trades at $123.5 (market cap $96.05B), while 10X Genomics Inc trades at $57.68 (market cap $7.61B). The key difference: Duke Energy Corp is far larger — about 12.6× 10X Genomics Inc's market cap, and Duke Energy Corp pays a 3.52% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

DUKTXG
Market Cap
$96.05B$7.61B
Sector
UtilitiesHealth
52-Week High
$133.46$58.57
52-Week Low
$113.99$11.34
Enterprise Value
$188.56B$7.14B
Dividend Yield
3.52%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Duke Energy Corp

Duke Energy (DUK) trades at $123.23, up 1.68% with a bearish technical signal despite strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.43 exceeding expectations, supported by growing revenue and healthy profit margins. Recent news highlights operational challenges from storms affecting customers but also strategic initiatives including a $35 million equity units offering and data center growth opportunities.

The outlook remains stable with analyst consensus pointing to upside potential (target $136.17) and no sell ratings. Key risks include regulatory scrutiny and capital expenditure pressures, but the company's dividend reliability and infrastructure investments provide long-term stability. The stock presents a balanced opportunity for income-focused investors amid current technical weakness.

10X Genomics Inc

TXG trades at $57.77, down 1.37% today, with a bullish technical outlook supported by moving averages and strong support at $55. The company shows improving fundamentals with Q2 2026 earnings beating estimates and positive cash flow trends, though it remains unprofitable with negative margins. Recent news highlights collaborations with major medical institutions and strategic acquisitions expanding multiomics capabilities.

Investment outlook is mixed: technical strength and analyst upgrades suggest near-term upside potential, but high valuation multiples and persistent losses pose significant risks. The stock faces pressure from competitive threats and execution challenges in achieving profitability, requiring careful monitoring of upcoming Q3 earnings and revenue growth sustainability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Duke Energy Corp

Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure

Read more on DUK

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG